Search

everythinglearnresearchcommunity

for

Search:↓

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Janus kinase inhibitors may help treat lichen planopilaris.

Three compounds from Dadap leaves may help treat hair loss.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.

Patients with alopecia areata using Janus kinase inhibitors are not following lab monitoring guidelines.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Infections during JAK inhibitor treatment for alopecia areata are usually manageable and rarely stop treatment permanently.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Tofacitinib treatment for hair loss may worsen acne.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Upadacitinib effectively treated severe hair loss in a child.

Ruxolitinib cream may help treat severe hair loss in children.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.